AstraZeneca

AstraZeneca quietly sweeps out some notable mid-stage drug programs
Fierce Biotech
Thu, 02/6/14 - 08:38 am
AstraZeneca
MEDI-5117
AZD8330
AZD6765
MEDI-557
MEDI-575
AZD5423
AZD7594
AZD1446
AZD3480
AZD5213
AstraZeneca steps up its global restructuring with 550 new job cuts
Fierce Pharma
Thu, 02/6/14 - 08:35 am
layoffs
AstraZeneca
AstraZeneca profits heading south as patent losses bite
Yahoo/Reuters
Thu, 02/6/14 - 06:51 am
AstraZeneca
earnings
patents
The top 10 pharma companies in social media
Fierce Pharma Marketing
Wed, 02/5/14 - 09:55 am
social media
JNJ
GSK
Novo Nordisk
UCB Pharmaceuticals
Pfizer
Boehringer Ingelheim
Novartis
Bayer
Merck
AstraZeneca
AstraZeneca's Prescription for Growth
Yahoo/TheStreet.com
Wed, 02/5/14 - 08:50 am
AstraZeneca
earnings
Glaxo’s Advair Loses U.S. Market Share to Astra, Merck
Bloomberg
Tue, 02/4/14 - 06:54 pm
GSK
Advair
AstraZeneca
Merck
COPD
WSJ: Scientist's lawsuit accuses AstraZeneca of fudging Brilinta study
Fierce Pharma
Mon, 02/3/14 - 10:48 am
Brilinta
AstraZeneca
AstraZeneca Wins One Battle, But Loses Another (And Perhaps the War) on SYMBICORT Patent Term Extension
FDA Law Blog
Mon, 02/3/14 - 09:26 am
Symbicort
AstraZeneca
patents
Bristol-Myers Squibb Completes Previously Announced Sale of Global Diabetes Business to AstraZeneca
Yahoo
Mon, 02/3/14 - 08:52 am
M&A
diabetes
Bristol-Myers Squibb
AstraZeneca
AstraZeneca Vs. NTDs: Does Profitability Win Out?
Seeking Alpha
Mon, 02/3/14 - 08:31 am
AstraZeneca
India
R&D
AstraZeneca joins stepped-up antibiotic R&D action with FOB Synthesis deal
Fierce Pharma
Wed, 01/29/14 - 10:22 am
AstraZeneca
antibiotics
R&D
FOB Synthesis
carbapenem
3 Reasons to Focus on Diabetes
Motley Fool
Tue, 01/28/14 - 10:53 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Xigduo
Pfizer
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Seeking Alpha
Tue, 01/28/14 - 08:50 am
Bristol-Myers Squibb
nivolumab
AstraZeneca
What Are AstraZeneca plc’s Dividend Prospects Like Beyond 2014?
Motley Fool
Mon, 01/27/14 - 09:14 am
AstraZeneca
dividends
There’s A Patent Cliff But AstraZeneca Has A Jetpack
Motley Fool
Thu, 01/23/14 - 10:43 am
patents
patent cliff
AstraZeneca
Crestor
Symbicort
AstraZeneca's Soriot faces off against skeptics, preaches late-stage R&D revival
Fierce Biotech
Tue, 01/14/14 - 08:30 am
R&D
Pharma CEOs
Pascal Soriot
AstraZeneca
AstraZeneca sees 2017 revenue in line with 2013 level
Yahoo/Reuters
Tue, 01/14/14 - 08:07 am
earnings
AstraZeneca
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bloomberg
Wed, 01/8/14 - 04:20 pm
Dapagliflozin
FDA
Bristol-Myers Squibb
diabetes
AstraZeneca
Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion
Fierce Pharma
Wed, 01/8/14 - 11:11 am
Roche
Teva
AstraZeneca
biosimilars
M&A
Celltrion
South Korea
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal
Yahoo/Reuters
Wed, 01/8/14 - 08:09 am
Immunocore
AstraZeneca
MedImmune

Pages